According to FutureWise analysis, the market for Age Related Macular Degeneration Drug is estimated to be US$ 11.29 billion in 2023 and is expected to reach US$ 19.57 billion by 2031 at a CAGR of 7.1% over the forecast period of 2024-2032.
Age-related macular degeneration (AMD) is a significant eye disease affecting older adults, which blurred central vision due to damage to the macula, a crucial part of the retina. The macula is a specialized area of the retina that processes detailed visual information. Dry AMD (also known as atrophic AMD) and wet AMD (advanced neovascular AMD) are the two types of AMD. Dry AMD can be seen in most cases and is characterized by progressive macular thinning due to aging. This type of AMD progresses through three distinct stages: early, intermediate, and late. Wet AMD is seen rarely but is a more aggressive form of the condition, usually resulting in more rapid vision loss. It occurs exclusively in the late stage and can develop from any location of dry AMD. There is significant growth of abnormal blood vessels seen in the back of the eye, which can cause substantial damage to the macula and is a characteristic of dry AMD.
Treatment options are seen based on the type and stage of the disease. No specific treatment exists for early AMD, and regular eye exams are crucial for monitoring. Practicing a healthy lifestyle, including a balanced diet, regular exercise, and quitting smoking, can be beneficial. If an individual has intermediate AMD in one or both eyes, special dietary supplements containing vitamins and minerals may be recommended to prevent its progression to late AMD. These supplements may also be beneficial for slowing down the advancement of AMD in the other eye if late AMD is present in only one eye. For individuals with wet AMD, targeted treatments are available to halt further vision loss potentially. These include administering anti-VEGF drugs through eye injections and photodynamic therapy (PDT), which combines injections with laser treatment.
FutureWise Market Research has published a report that provides an insightful analysis of Age-Related Macular Degeneration Drug Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Age Related Macular Degeneration Drug Market will experience a significant growth.
According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.